| RNA Selection: Aptamers achieve the desired recognition Current Biology, Volume 4, Issue 5, 1 May 1994, Pages 427-429 Andrew D. Ellington Summary selection procedures can generate RNA molecules, known as aptamers, that bind pre-determined ligands with an affinity and selectivity comparable to highly evolved protein molecules. Summary | Full Text | PDF (524 kb) |
| Design of allosteric hammerhead ribozymes activated by ligand-induced structure stabilization Structure, Volume 7, Issue 7, 15 July 1999, Pages 783-791 Garrett A Soukup and Ronald R Breaker Summary An adaptive strategy for modular rational design has proven to be an effective approach to the engineering of novel allosteric ribozymes. This strategy was used to create allosteric ribozymes that function by a mechanism involving ligand-induced structure stabilization. Conceivably, similar engineering strategies and allosteric mechanisms could be used to create a variety of novel allosteric ribozymes that function with other effector molecules. Summary | Full Text | PDF (108 kb) |
| Methylxanthine Drugs Are Chitinase Inhibitors: Investigation of Inhibition and Binding Modes Chemistry & Biology, Volume 12, Issue 9, 1 September 2005, Pages 973-980 Francesco V. Rao, Ole A. Andersen, Kalpit A. Vora, Julie A. DeMartino and Daan M.F. van Aalten Summary Family 18 chitinases play key roles in a range of pathogenic organisms and are overexpressed in the asthmatic lung. By screening a library of marketed drug molecules, we have identified methylxanthine derivatives as possible inhibitor leads. These derivatives, theophylline, caffeine, and pentoxifylline, are used therapeutically as antiinflammatory agents, with pleiotropic mechanisms of action. Here it is shown that they are also competitive inhibitors against a fungal family 18 chitinase, with pentoxifylline being the most potent (K of 37 μM). Crystallographic analysis of chitinase-inhibitor complexes revealed specific interactions with the active site, mimicking the reaction intermediate analog, allosamidin. Mutagenesis identified the key active site residues, conserved in mammalian chitinases, which contribute to inhibitor affinity. Enzyme assays also revealed that these methylxanthines are active against human chitinases. Summary | Full Text | PDF (377 kb) |
Copyright © 2000 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 78, Issue 4, 1703-1713, 1 April 2000
doi:10.1016/S0006-3495(00)76722-1
Biophysical Theory and Modeling
Peet Kask*, †, Kaupo Palo*, Nicolas Fay*, Leif Brand*, Ülo Mets*, Dirk Ullmann*, Joern Jungmann*, Johannes Pschorr* and Karsten Gall*,
, 
* EVOTEC BioSystems AG, D-22525 Hamburg, Germany
† Institute of Experimental Biology, Harku 76902, Estonia
Address reprint requests to Dr. Karsten Gall, EVOTEC BioSystems AG, Schnackenburgallee 114, D-22525 Hamburg, Germany. Tel.: 49-40-560-81-0; Fax: 49-40-560-81-222.Fluorescence intensity distribution analysis (FIDA; Kask et al; independently Chen et al) has been recently developed as a complement to fluorescence correlation spectroscopy (FCS; Magde et al). The general idea of FIDA was introduced in 1990 (Qian and Elson, 1990a,Qian and Elson, 1990b), but then realized as a less powerful method of moment analysis (MAFID). As in most common versions of FCS, in first realizations of MAFID and FIDA, a single detector was used to monitor fluorescence from a microscopic sample volume. However, fluorescence fluctuation spectroscopy does not have to be restricted to the use of a single detector. For different purposes, two detectors have been used in some applications of FCS. In the nanosecond time domain, the two-detector system has been applied simply because the dead time of the detector would otherwise not permit correlation studies on such a short time scale (Kask et al). In rotational correlation studies, two detectors have been used for monitoring light of different polarization, which helps one to distinguish fluctuations of light intensity due to rotational motion of particles from intensity fluctuations of other origin (Kask et al). Furthermore, in some cross-correlation studies two detectors monitor light of different colors originating from different fluorophores, enabling one to estimate to what extent two labeled molecules are bound to each other (Schwille et al). The present paper introduces the theory of FIDA with two detectors. The two-dimensional FIDA (2D-FIDA), if used with a polarization cube, is a tool that can distinguish fluorescent species with different specific polarization ratios. Alternatively, if two-color equipment is used, the 2D-FIDA can determine concentrations and specific brightness values of fluorescent species corresponding to individual labels as well as their complex.
The presented method is well suited for monitoring molecular interactions including receptors and ligands or antibodies and antigens, which are both of great relevance in the life sciences. The method is extremely accurate if the assay of interest can be designed with a significant contrast in specific brightness between bound and unbound states. Furthermore, it is characterized by single molecule sensitivity, the ability to resolve different species and determine their absolute concentrations, and to detect coincidences of different molecules in time and space. It is a homogeneous method, i.e., washing steps are not required. It is fast, well miniaturizable, and as a confocal technique, insensitive to surface adsorption. Therefore, 2D-FIDA is expected to find a wide variety of applications. Our pharmaceutical applications already cover the scale from detailed biochemical assay development to primary drug screening.
To elaborate a simple theory that enables one to express the expected two-dimensional distribution of the number of photon counts, it is favorable to use the same assumptions used in one-dimensional FIDA and its predecessor, the moment analysis of photon count number distribution. The assumptions are as follows. 1) Coordinates of particles are random and independent of each other; 2) contribution to fluorescence intensity from a particle can be expressed as a product of a specific brightness of the particle and a spatial brightness profile function characteristic of the optical equipment; and 3) a short counting time interval T is selected, during which the brightness of fluorescent particles does not significantly change due to translational diffusion.
We shall first express a joint distribution of count numbers from a single fluorescent species and a single small open volume element dV. The latter is a small fraction of the microscopic observable volume, where the spatial brightness is considered to be constant. Let us characterize the volume element by coordinates r and spatial brightness B(r), and the fluorescent species by its specific brightness values q1 and q2. By q1 and q2 we have denoted the mean photon count rates by two detectors from a particle situated at a point where B(r)=1. The spatial brightness function describes the varying excitation and detection conditions across the observed volume. A convenient choice is to select a unit of B, as usual in FCS, by the equation χ1=χ2, where χk=ʃBk (r)d3r. If the volume element contains m particles, then the expected mean photon count numbers per time interval T from the volume element are mq1TB(r) and mq2TB(r), while the joint distribution of the numbers of photon counts from m particles is Poissonian for both detectors independently:
![]() | (1) |
![]() | (2) |
![]() |
![]() |
![]() | (4) |
![]() |
![]() |
![]() |
![]() | (6) |
The spatial brightness function is accounted for through the spatial integration on the right side of Eq. (6). In the same way as in 1D-FIDA, the three-dimensional integration can be reduced to one dimension by replacing the three-dimensional coordinates r by a one-dimensional variable, a monotonic function of the spatial brightness B(r). A convenient choice of the variable is x=ln[B(0)/B(r)]. A sufficiently flexible model of the one-dimensional spatial brightness profile is presented in the following expression:
![]() | (7) |
would yield.) Empirical values of the constants a1 and a2 of our equipment are in the vicinity of a1≈ −0.4 and a2≈ 0.08. However, the values of a1 and a2 are highly correlated, and therefore it is recommended to present at least one of them with a higher than the nominal accuracy of their determination (which is typically 5–10%).In the interval of obtained count numbers, the probability of obtaining a particular pair of count numbers usually varies by many orders of magnitude. Consequently, the variance of the experimental distribution also has a strong dependence on the count numbers. To determine weights for least-squares fitting, one can assume for simplification that coordinates of particles in all counting intervals are randomly selected. (Thus we ignore correlations of the coordinates in consecutive counting intervals.) In this assumption, we have a problem with distributing M events over choices of different pairs of count numbers n1, n2, each particular outcome having a given probability of realization, P(n1, n2). Covariance matrix elements of the distribution can be expressed as follows:
![]() |
![]() |
For a further simplification, one may ignore the second term on the right side of Eq. (8), which can be interpreted as a consequence of normalization. In this case, the weights are simply equal to the inverse values of the diagonal covariance matrix elements
![]() | (9) |
In Table 1 theoretical errors of FIDA and 2D-FIDA simulations are presented in two selected cases for two fluorescent species. In both cases the ratio of specific brightness values of the two species is three. Throughout the simulations, a data collection time of 8s, a counting time interval of 40μs, a diffusion time of 400μs for both species, a speed of scanning (or flow) of 11000 1/e2-radius values per second, and a background count rate of 1kHz were assumed. Note that the statistical error values of the estimated parameters are significantly lower in the 2D-FIDA example. This result is related to the design principle of the two color experiments recommending that the spectral sensitivities of the two detectors (A and B) are tuned to different species. The values of parameters in the 2D-FIDA example are selected symmetrically. The error values would also be equal in pairs if the number of realizations was significantly higher than 30.
In the same manner as one-dimensional FIDA can be generalized to the two-dimensional case, it can be done with MAFID. Factorial moments of the distribution P(n1, n2) are defined as
![]() | (10) |
![]() | (11) |
![]() | (12) |
![]() | (13) |
![]() | (14) |
In Table 2 statistical errors of 2D-FIDA and 2D-MAFID are presented as determined by generating a series of 30 random distributions of count numbers, simulated for identical “samples,” thereafter applying 2D-FIDA and 2D-MAFID and determining the variance of estimated parameters in both cases. It is evident that the advantages of 2D-FIDA compared to 2D-MAFID increase with the number of parameters to be estimated.
| Table 2 Statistical errors of 2D-FIDA and 2D-MAFID in a few selected cases |
| Data collection time, s | Number of species | Number of estimated parameters | Specification of cumulants used in 2D-MAFID | Specification of parameters | Parameter values | Error of 2D-FIDA, % | Error of 2D-MAFID, % | ||
|---|---|---|---|---|---|---|---|---|---|
| 2 | 1 | 3 | K01 | cV | 0.5 | 1.5 | 1.6 | ||
| K10 | qA | 60kHz | 1.6 | 1.8 | |||||
| K11 | qB | 40kHz | 1.8 | 1.9 | |||||
| 8 | 2 | 4 | K01 | c1V | 0.5 | 1.01 | 1.05 | ||
| K10 | c2V | 0.5 | 0.77 | 2.63 | |||||
| K02 | qA1 | 60kHz | 0.89 | 0.75 | |||||
| K20 | qA2 | 20kHz | (fixed) | (fixed) | |||||
| qB1 | 20kHz | 1.54 | 4.45 | ||||||
| qB2 | 60kHz | (fixed) | (fixed) | ||||||
| 8 | 3 | 5 | K01 | c1V | 0.2 | 2.6 | 3.4 | ||
| K10 | c2V | 0.2 | 1.5 | 1.8 | |||||
| K02 | c3V | 0.2 | 2.4 | 2.8 | |||||
| K11 | qA1 | 40kHz | 1.9 | 3.0 | |||||
| K20 | qA2 | 20kHz | (fixed) | (fixed) | |||||
| qA3 | 60kHz | (fixed) | (fixed) | ||||||
| qB1 | 10kHz | 5.4 | 8.2 | ||||||
| qB2 | 60kHz | (fixed) | (fixed) | ||||||
| qB3 | 70kHz | (fixed) | (fixed) | ||||||
| 8 | 2 | 6 | K01 | c1V | 0.5 | 1.9 | 4.6 | ||
| K10 | c2V | 0.5 | 1.5 | 4.8 | |||||
| K02 | qA1 | 60kHz | 1.1 | 1.8 | |||||
| K11 | qA2 | 20kHz | 1.6 | 4.3 | |||||
| K20 | qB1 | 20kHz | 1.5 | 4.7 | |||||
| K21 | qB2 | 60kHz | 1.0 | 1.7 | |||||
| Error values were calculated from the scattered results of analysis applied to a series of simulated data (see text for details). |
In Table 3 the relative deviation of mean values (i.e., bias) of estimated parameters are presented for 2D-FIDA and 2D-MAFID. In each case bias is determined from analysis of a series of 30 simulated random distributions of count numbers. Three cases were analyzed. In the first case, models used in data simulations and data analysis were identical. In the second case, the distributions of count numbers were simulated assuming that particles of the second species are not equivalent, but are distributed by their individual brightness with a relative half-width of 20%. However, we intentionally ignored this phenomenon in analysis. Of course, applying a slightly inadequate model for analysis produces bias of estimated parameters. The third case is similar to the second one except that the relative half-width of the individual brightness distribution of the second species is 50%, which is a usual value for vesicular preparations. It is worth noting that methodological deviations are noticeable when mapping weighted residuals of 2D-FIDA in cases two and three. However, 2D-FIDA still returns meaningful results, while 2D-MAFID is much more sensitive to model deviations.
| Table 3 Bias values of 2D-FIDA and 2D-MAFID |
| Bias of 2D-FIDA, % | Bias of 2D-MAFID,% | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Parameter specification | Parameter value | Case 1 | Case 2 | Case 3 | Case 1 | Case 2 | Case 3 | ||
| c1V | 1.0 | +0.1±0.2 | −0.35 | −2.0 | +0.1±0.2 | −6.5 | −28 | ||
| c2V | 0.05 | +0.6±0.4 | −2.0 | −10.6 | +1.8±0.6 | −15.6 | −69 | ||
| qA1 | 20kHz | −0.1±0.2 | +0.8 | +5.0 | −0.3±0.3 | +10.0 | +58 | ||
| qA2 | 100kHz | −0.3±0.4 | −0.7 | −11.2 | −0.9±0.3 | +5.5 | +41 | ||
| qB1 | 1kHz | −1.2±0.5 | +2.6 | +20.6 | −6.7±3.0 | +75 | +563 | ||
| qB2 | 200kHz | −0.3±0.4 | +1.2 | +1.3 | −0.9±0.3 | +11.6 | +99 | ||
| In case 1, identical models were used in data simulation and analysis, while in cases 2 and 3, a less stringent model was used for analysis than in data simulation (see text for details). |
The central optical part of a 2D-FIDA experiment is a confocal microscope as it is used in fluorescence correlation spectroscopy (Koppel et al). For excitation of fluorescence, a beam from a continuous-wave laser is attenuated by neutral filters, passes a beam expander, and is directed to the microscope objective by a dichroic mirror. In a number of experiments with slowly diffusing particles, e.g., vesicles, beam scanning in combination with sample scanning is used, as a tool known from laser scanning microscopy. Fluorescence is collected by the same objective through the dichroic mirror and is focused to a confocal pinhole, which serves to reject the out-of-focus light. The light, which passes the pinhole, is divided by a beamsplitter for detection by two detectors. Depending on the general type of a 2D-FIDA experiment, the beamsplitter is either a polarization cube or a dichroic mirror. In the first case, a common spectral band-pass filter is used, while in the case of two-color FIDA, each detector has a different band-pass filter positioned in front of it (Fig. 1). The photon counting detectors are silicon avalanche photodiode modules (SPCM-AQ-131, EG&G Optoelectronics, Vaudreuil, Quebec, Canada). The TTL pulses from the detectors are collected continuously by a two-channel counter constructed at EVOTEC as a computer plug-in card that calculates the count number distributions in real time from the 32 MB onboard buffer. By feeding the detector outputs to a correlator, FCS measurements can be performed in parallel with FIDA experiments.
The levels of background count rate for both detectors are determined in a separate experiment on bidistilled water. The main contributor to the nonfluctuating background light intensity is Raman scattering from water.
The radius of the monitored sample volume can be adjusted by selecting an appropriate expansion factor of the original laser beam. The focal beam radius of ∼0.6μm is used, yielding diffusion times for simple organic dye molecules (e.g., 5′-(6-carboxytetramethylrhodamine (TAMRA)) of ∼260μs, which is considered long compared to the 40μs dwell time of counters, so that the assumption of constant molecular brightness during the counting interval is well-founded. The excitation intensity is adjusted as a compromise between a high count rate per molecule and low population of the triplet state. In our experiments we have kept the triplet state population below 15% because higher triplet population values might significantly distort the apparent spatial brightness profile (Kask et al).
For methodological test experiments two different dyes were selected, TAMRA and rhodamine red X (RRX). These dyes have different emission spectra and different extinction coefficients at the excitation wavelength of 543.5nm. In these experiments, a wideband 40/60 beamsplitter was used in front of the detectors. The spectral filter of the “red” channel has the central wavelength of 605nm and FWHM of 50nm, while the corresponding figures for the “yellow-green” channel are 575nm and 30nm. The dyes were diluted in distilled water so that the average number of molecules in the observation volume was in the range of 0.5–2.0, corresponding to concentrations between 0.23 and 0.92 nM. For each experiment ∼20μl of the sample solution was placed on a coverslip separating the sample from the water immersion objective (Zeiss C-Apochromat 40×1.2W Korr). All the dyes were measured separately for 60s, as were their mixtures with two different concentration ratios (∼1:1 and 1:2.5). The parameters describing the spatial brightness profile were determined from adjustment experiments on TAMRA and were fixed for the subsequent analysis of other samples at values a1=−0.405 and a2=0.0772.
As an example, Fig. 2 visualizes a joint count number distribution of an ∼0.5nM TAMRA solution. The results of the above-described test experiments are summarized for multiple realizations in Table 4. We have not specified samples by concentration values calculated from dilution factors of the preparation because adsorption of dye molecules to glass surfaces may influence the real concentrations in the sample volume. Therefore, the determined concentration values vary slightly from realization to realization. However, the specific brightness values are well-reproduced throughout all experiments.
| Table 4 Results of 2D-FIDA applied to solutions of TAMRA, RRX, and their mixture |
| Sample | Number of realization | Mean number of molecules per sample volume, cV | Specific brightness in “red,” q1, kHz | Specific brightness in “yellow-green,” q2, kHz | ||
|---|---|---|---|---|---|---|
| TAMRA | 1 | 1.128±0.004 | 79.6±0.3 | 51.3±0.2 | ||
| 2 | 1.139 | 79.4 | 50.9 | |||
| 3 | 1.160 | 79.4 | 50.8 | |||
| 4 | 1.171 | 79.0 | 50.6 | |||
| RRX | 1 | 1.892±0.007 | 48.0±0.2 | 15.63±0.06 | ||
| 2 | 1.859 | 48.0 | 15.63 | |||
| 3 | 1.850 | 47.3 | 15.44 | |||
| 4 | 1.811 | 47.9 | 15.58 | |||
| TAMRA and RRX, (approx. 1:1) | 1 | 0.99±0.03 | 78.0±0.8 | 51.8±0.7 | ||
| 1.14±0.03 | 49.1±0.5 | 15.0±0.4 | ||||
| 2 | 1.01 | 76.8 | 51.1 | |||
| 1.08 | 49.5 | 15.1 | ||||
| 3 | 0.99 | 77.9 | 51.8 | |||
| 1.03 | 49.3 | 15.1 | ||||
| 4 | 0.97 | 76.9 | 51.7 | |||
| 1.03 | 50.0 | 15.5 | ||||
| TAMRA and RRX, (approx. 1:2.5) | 1 | 0.93±0.03 | 74.6±0.8 | 49.6±0.9 | ||
| 2.51±0.04 | 47.6±0.3 | 14.7±0.2 | ||||
| 2 | 0.98 | 75.2 | 49.2 | |||
| 2.38 | 46.8 | 14.2 | ||||
| 3 | 0.96 | 75.0 | 49.4 | |||
| 2.25 | 48.0 | 14.7 | ||||
| 4 | 0.94 | 76.1 | 49.9 | |||
| 2.16 | 47.6 | 14.8 | ||||
It is worth noting that distributions measured with mixtures are qualitatively different from those measured for pure dyes. Fig. 3 visualizes weighted residuals of fitting a distribution measured with a mixture of TAMRA and RRX. The top graph (A) corresponds to the adequate analysis when two species were assumed to be present; residuals are scattered quite randomly and uniformly. The bottom graph (B) corresponds to the assumption that only a single species is present. Here a significant difference between the measured and the calculated distribution is evident.
In the following section we shall present in detail two essentially different examples of 2D-FIDA from biochemical assay development illustrating the broad applications of the method. As outlined in the introduction of this paper it is essential that the two detectors monitor different qualities of fluorescent species. Therefore, in the first example the two detectors monitor the two polarization components of fluorescence, while in the second example the two detectors have different spectral responses, thus monitoring different labels.
In conventional fluorescence polarization studies, average intensities of two polarization components of fluorescence are directly measured. Fluctuations of the intensities are not of direct interest, but are considered rather as a source of statistical errors. The conventional fluorescence polarization method has proven to be a powerful tool in the study of molecular interactions (Checovich et al,Jameson and Sawyer, 1995,Jolley, 1996). Changes in the fluorescence polarization values of a sample containing a fluorescently labeled binding partner reflect changes in molecular volume and, hence, provide direct information on equilibrium binding. Fluorescence polarization measurements can also be performed in real time, allowing the kinetic analysis of association and dissociation reactions. One of the most widely used fluorescence polarization applications is the competitive immunoassay used for the detection of therapeutic and illicit drugs. The method of fluorescence polarization has been used for clinical immunoassays for more than a decade (Jolley, 1981). The homogeneous FPIA (fluorescence polarization in immunoassays) has well-accepted advantages over conventional heterogeneous immunoassays like RIA or ELISA. However, it fails if multiple-binding step reactions are to be investigated because the separation of individually polarized species is impossible. Therefore, ligand-binding curves demonstrate only the overall decrease of polarization, meaning that the mechanistic binding constants cannot be determined. Further limitations are seen in sample volume and in mass restrictions.
With 2D-FIDA the full content of information usually buried in fluorescence anisotropy can be used, thereby overcoming the limitations mentioned above. 2D-FIDA directly determines two specific quantities per fluorescent species in one measurement: the fluorescence intensity per molecule and the anisotropy of a given model. Based on this supplementary information, the delineation of all participating species and even the quantification of the binding behavior are possible. 2D-FIDA anisotropy is an ideal tool for the quantitative description of systems exhibiting multiple binding steps, aggregation, and multimerization phenomena as demonstrated with the following example.
Theophylline therapy has been a cornerstone of asthma therapy for several years and, therefore, there is a strong demand for assaying and fine-tuning the theophylline level in serum (Hinds et al,Poncelet et al,Mallin et al). To demonstrate the capabilities of 2D-FIDA we have investigated the binding of theophylline antigens to anti-theophylline antibodies from a polyclonal anti-theophylline serum (Europe Research Products, Cambridge, UK; Cat. no. RPCR2079R). This two step binding reaction can be described by the reaction scheme shown in the top part of Fig. 5. It assumes the existence of two identical but independent binding sites. The antigens were labeled with TAMRA using standard labeling procedures. They exhibited in classical FP analysis a low anisotropy value of 0.055 upon interacting with the antibody. Therefore they form a critical basis for illustrating the sensitivity of 2D-FIDA.
For the binding experiments the stock solutions of antibody and antigens were diluted in a PBS buffer with 0.05% Tween 20. After mixing the compounds, the mixture was incubated for 30min at room temperature. Matching the spectral properties of the conjugates, the system was excited at the 543.5nm line of an He/Ne laser (Uniphase, San Jose, CA, USA). As two examples, measured joint distributions of photon count numbers and results of 2D-FIDA applied to samples at different antibody dilution values but a constant ligand concentration of 2 nM are illustrated by Figure 4 and Figure 5. Antibody concentrations are in arbitrary units referring to effective dilutions. Water background was below 1kHz in each detection channel.
For the two-color approach of 2D-FIDA, the two detectors are spectrally tuned to monitor fluorescence from two labels of different color. In the assay type described below, ligand molecules are labeled in “green.” Because each vesicle carries a large number of receptors, vesicles in samples with a low binding degree can be distinguished from vesicles in samples with a high binding degree by a significantly higher specific brightness in “green.” Vesicles are additionally stained in “red.” Specific brightness of vesicles in “red” is not altered by binding of ligand molecules, but staining in “red” is a means to increase contrast between free ligand molecules (which are nearly invisible in “red”) and vesicles (which in the case of extremely low binding may be of nearly the same brightness in “green” as free ligand molecules). Contributions from the two fluorescent species of a single sample to the measured joint distribution of the numbers of photon counts are very different in this assay type indeed, and therefore the analysis is extremely reliable.
To demonstrate the advantages of 2D-FIDA the binding of TAMRA-labeled somatostatin-14 (SMS–14–5TAMRA) to small membrane vesicles carrying the human type-2 high-affinity somatostatin receptor SSTR-2 (Schoeffter et al) was chosen as a biological test system. The top part of Fig. 7 illustrates the principle of the assay.
Membrane vesicles were prepared from CCL39 hsst2 cells overexpressing the receptor. The cells were disrupted in vesicle buffer [10mM HEPES, pH 7.6 (KOH), 5mM MgCl2] in the presence of protease inhibitors [Complete™ EDTA free (Roche Diagnostics GmbH, Mannheim, Germany) according to manufacturer's instructions with additional 0.2mg/ml soybean trypsin inhibitor and 0.5mg/ml bacitracin] using a glass homogenizer (Dounce homogenizer). Cell nuclei and intact cells were removed by centrifugation at 900×g for 5min and the supernatant was recentrifuged at 48,000×g for 30min. After sedimentation the membranes were washed and resuspended in vesicle buffer and homogenized at maximum speed for 8s using a Polytron homogenizer (Kinematica AG, Littau, Switzerland). Large particles were removed by centrifugation at 900×g for 1min and the supernatant containing small vesicles was used for binding experiments.
The receptor binding reaction was performed in vesicle buffer in the presence of protease inhibitors (see above), 0.01% (w/v) fluorosurfactant FC-135, 1.3% (v/v) DMSO and vesicles, corresponding to a total protein concentration of ∼0.6mg/ml, stained by 10 nM of the lipophilic tracer DiIC18(5) (Molecular Probes Europe BV, Leiden, The Netherlands).
For excitation of fluorescence of the two spectrally distinct labels, the 532-nm line of an Nd:Yag laser attenuated to 250μW and the 632-nm line of a He-Ne laser attenuated to 25μW were simultaneously used. To minimize misalignment of the two laser beams, they both passed through a single optical fiber before being focused by the microscope. An optical band-pass filter with a central wavelength of 590nm, FWHM 60nm, and another one with a central wavelength of 690nm, FWHM 40nm were used in front of the two detectors, monitoring fluorescence from the two labels separately. Because vesicles are slowly diffusing particles, in these experiments an area of 0.05mm2 of each sample was scanned, using sinusoidal beam scanning of 25Hz frequency, 100μm amplitude in one direction, and sample scanning of 500μm per 8s data collection time in the other direction.
In Fig. 6 two typical examples of count number distributions corresponding to a high and a low degree of binding are compared. In Figure 6A the vesicle-bound ligand (SMS-14–5TAMRA) was competed off by the addition of a large excess of nonfluorescent competitor [SRIF-14 (Sigma, Deisenhofen, Germany), 1μM competitor, 3 nM total ligand]. It is clearly visible that the distribution obtained in the absence of competitor (Figure 6B) is more expanded in the n2 direction than in the presence of competitor. The n2 direction represents the green fluorescence of the labeled ligand and, hence, is a measure of the ligand binding.
Using a fit model that accounts for two different species, both the concentration (particle number in the confocal volume) and the fluorescence brightness values for the free ligand and the ligand bound to vesicles were obtained. The vesicles are well distinguished from the free ligand even in the presence of competitor (low binding). As expected, addition of competitor leads to a decrease in the green fluorescence of the vesicles and an increase in the concentration of free ligand (Fig. 7). The fact that the ligand does not completely dissociate from the vesicles is due to unspecific binding, which depends on the amount of vesicles used in the assay.
Next, we titrated the competitor from 1μM down to 10pM (10 measurements each) to record a dose-response curve and to determine the EC50 value. As shown in Fig. 8, 2D-FIDA analysis leads to a typical sigmoidal competition curve with very low standard deviations. The calculated EC50 value of 0.87nM is in good agreement with EC50 values obtained using other evaluation methods (data not shown). Thus, it is not only possible to differentiate between high and low binding, but also small changes in the binding degree can be resolved with 2D-FIDA with high accuracy. This is of particular importance if one aims to identify assay inhibitors (“hits”) in high throughput drug screening.
In this paper we extended the theory of fluorescence intensity distribution analysis (FIDA) to two dimensions. By comparing theoretical with experimental data we could prove that the collected joint photon count number distributions are in agreement with the theoretically predicted ones. The introduction of the generating function facilitates data evaluation and makes the method applicable even in high throughput drug screening, where it has already been successfully applied (EVOTEC/Novartis collaboration).
Compared to many other fluctuation methods, which often suffer from low precision, the presented method can be extremely accurate. In fact, the accuracy depends on the skill of assay design; a very important nuance is that fluorescence from different species was split at different intensity ratios. Only in the case of the worst design, when fluorescence from different species is split between the two detectors at the same ratio, is the resolving power of 2D-FIDA equal to that of 1D-FIDA. The higher the contrast between species in the intensity ratio, the more one can gain from using 2D-FIDA.
2D-FIDA has proven to be a method of versatile applicability. It offers new insights into polarization studies. Compared to a number of other polarization methods, it is superior due to its ability to separate different components and determine their absolute concentrations. Among different fluorescence methods we have compared with 2D-FIDA, only the polarization analysis by burst integrated fluorescence lifetime (BIFL; Schaffer et al) has both of these properties. However, BIFL is restricted to significantly lower concentrations than 2D-FIDA.
The other branch of 2D-FIDA, the two-color analysis, offers the possibility to work under near-to-ideality conditions because here assays can be designed or selected with a pronounced contrast between the bound and non-bound states. The closest method to two-color 2D-FIDA is its counterpart in FCS, the cross-correlation method. Between them, 2D-FIDA seems to be a more favorable method again, because FIDA is directly focused to separate the absolute concentrations of different components, whereas in FCS only the product of the concentration and the square of the specific brightness of each component can be directly separated.
The authors gratefully acknowledge NOVARTIS PHARMA AG for providing the SMS model. Dr. Nicholas Hunt is acknowledged for critically reading the manuscript.
Checovich et al., 1995 (1995). Fluorescence polarization—a new tool for cell and molecular biology. Nature 375, 254–256. CrossRef | PubMed
Chen et al., 1999 (1999). The photon counting histogram in fluorescence fluctuation spectroscopy. Biophys. J. 77, 553–567. Abstract | Full Text | PDF (221 kb) | CrossRef | PubMed
Hinds et al., 1984 (1984). Ligand displacement immunoassay: a novel enzyme immunoassay demonstrated for measuring theophylline in serum. Clin. Chem. 30, 1174–1178. PubMed
Jameson and Sawyer, 1995 (1995). Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246, 283–300. CrossRef | PubMed
Jolley, 1981 (1981). Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. J. Anal. Tox. 5, 236–240. PubMed
Jolley, 1996 (1996). Fluorescence polarization assays for the detection of proteases and their inhibitors. J. Biomol. Screening 1, 33–38. PubMed
Kask et al., 1999 (1999). Fluorescence-intensity distribution analysis and its application in biomolecular detection technology. Proc. Natl. Acad. Sci. USA 96, 13756–13761. CrossRef | PubMed
Kask et al., 1985 (1985). Fluorescence correlation spectroscopy in the nanosecond time range: photon antibunching in dye fluorescence. Eur. Biophys. J. 12, 163–166. PubMed
Kask et al., 1989 (1989). Separation of the rotational contribution in fluorescence correlation experiments. Biophys. J. 55, 213–220. Abstract | | CrossRef | PubMed
Koppel et al., 1976 (1976). Dynamics of fluorescence marker concentration as a probe of mobility. Biophys. J. 16, 1315–1329. Abstract | | CrossRef | PubMed
Magde et al., 1972 (1972). Thermodynamic fluctuations in a reacting system—measurement by fluorescence correlation spectroscopy. Phys. Rev. Lett. 29, 704–708. PubMed
Mallin et al., 1990 (1990). Determination of theophylline serum level: comparison between a rapid test (enzyme-immuno-chromatography) and conventional fluorescence polarization immunoassay. Pneumologie 44, 967–969. PubMed
Poncelet et al., 1990 (1990). Immunoassay of theophylline by latex particle counting. J. Immunoassay 11, 77–88. PubMed
Qian and Elson, 1990a (1990). Distribution of molecular aggregation by analysis of fluctuation moments. Proc. Natl. Acad. Sci. USA 87, 5479–5483. CrossRef | PubMed
Qian and Elson, 1990b (1990). On the analysis of high order moments of fluorescence fluctuations. Biophys. J. 57, 375–380. Abstract | | CrossRef | PubMed
Schaffer et al., 1999 (1999). Identification of single molecules in aqueous solution by time-resolved fluorescence anisotropy. J. Phys. Chem. 103, 331–336. PubMed
Schoeffter et al., 1995 (1995). Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain—identity with SSTR-2 receptors. Eur. J. Pharmacol. 289, 163–173. PubMed
Schwille et al., 1997 (1997). Dual-color fluorescence cross-correlation spectroscopy for multicomponent diffusional analysis in solution. Biophys. J. 72, 1878–1886. Abstract | | CrossRef | PubMed